Kilitch Drugs (India) Ltd.
KILITCH Share PricePharmaceuticals & Drugs
₹362.9
-7 (-1.9%)
As on September 8, 2025
Exchange Scrips: BSE524500NSEKILITCHISININE729D01010
Market Cap ₹ 637 Cr
P/E Ratio 40.84
Dividend Yield N/A
Performance
Market performance
Open373.25
High383.4
Volumes25,755
Prev362.9
Low355.2
As on2025-09-08
Historical performance
1 Year High500
3 Year High500
5 Year High500
1 Year Low293.53
3 Year Low122.32
5 Year Low76.92
Fundamentals
Company Valuation
Market Cap (₹Cr)
637
Face Value (₹)
10
P/E Ratio
40.84
Dividend Yield
N/A
Investment Returns
1 Year
8.9%
3 Years
123.7%
5 Years
336.5%
10 Years
1046.3%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 360.11 | Bullish |
| 10-DMA | 359.93 | Bullish |
| 20-DMA | 392.51 | Bearish |
| 50-DMA | 420.89 | Bearish |
| 100-DMA | 415.22 | Bearish |
| 200-DMA | 367.56 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 4 | 4 | 4 | 4 | 3 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 4 | 4 | 4 | 4 | 3 |
| Public Investors | 10375 | 9745 | 10135 | 9916 | 9617 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 40.84.
- 3Y Stock Price CAGR of the stock is 29.4.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹287 Million.
- The company generated revenue of ₹1544 Million in the previous financial year.
Kilitch Drugs (India) Ltd.
362.9-7 (-1.9%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1089429.9
No. of Shares: 3002 (Approx)
Performance:8.9%
P/L: ₹89429.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent